TGA / PMDA / NMPA · Asia-Pacific
meningococcal — TGA / PMDA / NMPA regulatory status
meningococcal regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Structured fields
- 4
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 21 published clinical programs and 1 related patent record. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| 220030 | Phase 3 | GSK Glaxo Smith | 2024-519549-31-00 |
| MEQ00073 | Phase 3 | Sanofi Pasteur MSD | 2023-510145-25-00 |
| MEQ00074 | Phase 3 | Sanofi Pasteur MSD | NCT06228586 |
| MEQ00089 | Phase 3 | Sanofi Pasteur MSD | 2023-508177-85-00 |
| MET55 | Phase 3 | Sanofi Pasteur MSD | NCT04143061 |
| MenACWY-TT | Phase 3 | Pfizer | NCT03189745 |
| Mencevax ACWY | Phase 3 | GSK Glaxo Smith | NCT01154088 |
| Meningococcal vaccine GSK134612 | Phase 3 | GSK Glaxo Smith | NCT00758264, NCT01755689 |
| Nimenrix | Phase 3 | GSK Glaxo Smith | NCT00514904 |
| P170938J | Phase 3 | PARItec | 2024-513649-35-00 |
| batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4) | Phase 3 | CanSino Biologics | NCT06131554 |
| 217043 | Phase 2 | GSK Glaxo Smith | 2023-506449-40-00 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 8003112 | Meningococcal and pneumococcal conjugate vaccine and method of using same | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of meningococcal?
meningococcal currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get meningococcal regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to meningococcal?
This spoke lists 21 published programs associated with meningococcal in our pipeline index.